Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen R Chen

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Joint Commission Journal on Quality and Patient Safety|May 16, 2015
Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and familiesMichael L Rinke, Allen R Chen, Aaron M Milstone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Cancer|August 18, 2010
Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcomaDavid M Loeb, Robert F Hobbs, Amarachukwu Okoli, et al.
Pediatric Quality & Safety|April 4, 2022
Trainee-led Engagement of the Care Team Improves Application of an Institutional Blood Culture Clinical Decision Algorithm to Pediatric Oncology Inpatients: A Single-institution Quality Improvement ProjectKathryn M Lemberg, Danielle W Koontz, David J Young, et al.
Blood Advances|June 10, 2026
PT/Cy-based alloBMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemiaMargarita Dionysiou, Yiouli P Ktena, Challice L Bonifant, et al.
Pediatric Blood & Cancer|September 22, 2016
Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case reportAziza T Shad, Jeffrey S Huo, Courtney Darcy, et al.
Pediatrics|September 5, 2012
Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patientsMichael L Rinke, Allen R Chen, David G Bundy, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2016
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R Klein, Allen R Chen, Christopher Gamper, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Joint Commission Journal on Quality and Patient Safety|May 16, 2015
Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and familiesMichael L Rinke, Allen R Chen, Aaron M Milstone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Cancer|August 18, 2010
Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcomaDavid M Loeb, Robert F Hobbs, Amarachukwu Okoli, et al.
Pediatric Quality & Safety|April 4, 2022
Trainee-led Engagement of the Care Team Improves Application of an Institutional Blood Culture Clinical Decision Algorithm to Pediatric Oncology Inpatients: A Single-institution Quality Improvement ProjectKathryn M Lemberg, Danielle W Koontz, David J Young, et al.
Blood Advances|June 10, 2026
PT/Cy-based alloBMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemiaMargarita Dionysiou, Yiouli P Ktena, Challice L Bonifant, et al.
Pediatric Blood & Cancer|September 22, 2016
Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case reportAziza T Shad, Jeffrey S Huo, Courtney Darcy, et al.
Pediatrics|September 5, 2012
Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patientsMichael L Rinke, Allen R Chen, David G Bundy, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2016
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R Klein, Allen R Chen, Christopher Gamper, et al.
Pageof 6